Quarterly report · Q2
2931.TEDINET S100RO90
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥44.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.6bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | −¥760m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | −¥639m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥597m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥618m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥595m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥914m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥465m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥913m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥462m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥60.8bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥57.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥58.6bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.1bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥37.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.7bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.4bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.9bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥16.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥500m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥924m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥351m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥531m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-7.88 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.38 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.83 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.18 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.54 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥862m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥432m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥724m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥189m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥101m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥810m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥376m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥122m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥113m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | −¥611m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 627
| Item | Context | Value | Unit |
|---|---|---|---|
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2023-01-01 | |
| Current period end date | FilingDateInstant | 2023-06-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2023-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Comparative period end date | FilingDateInstant | 2022-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所（プライム市場） | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)出雲 充 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口） | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区浜松町２丁目１１－３ | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口) | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８－１２ | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社丸井グループ | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都中野区中野４丁目３－２ | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | 1776 HERITAGE DRIVE,NORTH QUINCY,MA 02171,U.S.A. | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)亀谷 誠一郎 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)東京都千代田区 | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)JP MORGAN CHASE BANK 385781（常任代理人 株式会社みずほ銀行 決済営業部） | |
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)ロート製薬株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)大阪府大阪市生野区巽西１丁目８－１ | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | 14 PORTE DE FRANCE,ESCH-SUR-ALZETTE,LUXEMBOURG,L-4360 | |
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)東京センチュリー株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区神田練塀町３ |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |